IOP, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.596
EU - Europa 625
AS - Asia 479
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 5.708
Nazione #
US - Stati Uniti d'America 4.595
CN - Cina 304
IT - Italia 241
SG - Singapore 156
FI - Finlandia 88
SE - Svezia 79
DE - Germania 78
FR - Francia 42
GB - Regno Unito 39
UA - Ucraina 27
IN - India 11
IE - Irlanda 10
RU - Federazione Russa 8
NL - Olanda 6
BR - Brasile 3
EU - Europa 3
HK - Hong Kong 3
AT - Austria 1
BY - Bielorussia 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
ID - Indonesia 1
KG - Kirghizistan 1
ME - Montenegro 1
MV - Maldive 1
NG - Nigeria 1
PL - Polonia 1
RS - Serbia 1
TW - Taiwan 1
UY - Uruguay 1
VN - Vietnam 1
Totale 5.708
Città #
Fairfield 805
Woodbridge 524
Chandler 436
Ann Arbor 364
Houston 317
Ashburn 316
Seattle 292
Wilmington 273
Cambridge 261
Jacksonville 119
Padova 118
Singapore 116
Princeton 82
Beijing 69
San Diego 69
Medford 57
Des Moines 54
Boardman 53
Nanjing 48
Helsinki 45
Roxbury 37
Santa Clara 21
Guangzhou 19
Shenyang 14
Jinan 12
New York 12
Hebei 11
Milan 11
Shanghai 11
Dublin 10
Dallas 9
London 9
Nanchang 8
Changsha 7
Jiaxing 7
Munich 7
Redwood City 7
Rome 7
Tianjin 7
Cagliari 6
Norwalk 5
Ogden 5
Paris 5
Verona 5
Hefei 4
Hounslow 4
Phoenix 4
Pune 4
Borås 3
Edinburgh 3
Falls Church 3
Fuzhou 3
Groningen 3
Hangzhou 3
Imola 3
Kharkiv 3
Kilburn 3
Los Angeles 3
Magherafelt 3
Trieste 3
Turin 3
Udine 3
Vicenza 3
Washington 3
Zhengzhou 3
Amsterdam 2
Berlin 2
Boara 2
Bologna 2
Boydton 2
Casalgrande 2
Faedis 2
Fort Worth 2
Gazzo 2
Haikou 2
Ningbo 2
Piove Di Sacco 2
Redmond 2
Rio de Janeiro 2
San Francisco 2
San Jose 2
Sant'elena 2
Selvazzano Dentro 2
Taiyuan 2
Xi'an 2
Baltimore 1
Bassano Del Grappa 1
Belgrade 1
Bend 1
Birmingham 1
Bishkek 1
Brno 1
Campodarsego 1
Carpeneto 1
Catford 1
Chengdu 1
Chicago 1
Chiswick 1
Chongqing 1
Cordignano 1
Totale 4.792
Nome #
Human bone marrow-derived CD133+ cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis. 157
The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. 154
A Sterilization Method for Decellularized Xenogeneic Cardiovascular Scaffolds 150
Guided Tissue Regeneration in Heart Valve Replacement: From Preclinical Research to First-in-Human Trials 147
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 141
Decellularized Allogeneic Heart Valves Demonstrate Self-Regeneration Potential after a Long-Term Preclinical Evaluation 137
Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery 135
Decellularized aortic conduits: could their cryopreservation affect post-implantation outcomes? A morpho-functional study on porcine homografts 135
Decellularized Cryopreserved Allografts as Off-the-Shelf Allogeneic Alternative for Heart Valve Replacement: In Vitro Assessment Before Clinical Translation 124
Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts 122
Multimodal label-free ex vivo imaging using a dual-wavelength microscope with axial chromatic aberration compensation 122
Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. 122
Preservation strategies for decellularized pericardial scaffolds for off-the-shelf availability 120
Nanopatterned acellular valve conduits drive the commitment of blood-derived multipotent cells 119
The Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine 119
The Rapidly Evolving Concept of Whole Heart Engineering 119
Mechanical testing of pericardium for manufacturing prosthetic heart valves 116
First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. 116
Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity 116
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile. 113
In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves 112
Native Bovine and Porcine Pericardia Respond to Load With Additive Recruitment of Collagen Fibers 111
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat 109
Fibrosis in tissue engineering and regenerative medicine: treat or trigger? 109
Alpha-Gal detectors in xenotransplantation research: a word of caution. 104
First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. 104
A Comprehensive Comparison of Bovine and Porcine Decellularized Pericardia: New Insights for Surgical Applications 104
Bioengineered percutaneous heart valves for transcatheter aortic valve replacement: a comparative evaluation of decellularised bovine and porcine pericardia 101
Decellularized Porcine Aortic Roots: Histopathology Features in an Experimental Animal Model of Right Ventricular Outflow Tract Reconstruction 100
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. 99
Xenotransplantation: The Way beyond and Ahead toward Clinical Application 95
RegenHeart: A Time-Effective, Low-Concentration, Detergent-Based Method Aiming for Conservative Decellularization of the Whole Heart Organ 94
The vietnamese pig as a translational animal model to evaluate tissue engineered heart valves: Promising early experience 92
The Biocompatibility Challenges in the Total Artificial Heart Evolution 91
Biocompatibility Evaluation Criteria for Novel Xenograft Materials: Distribution and Quantification of Remnant Nucleic Acid and Alpha-Gal Epitope 86
Stem Cell Populations in Human Heart Valves: Identification, Isolation and Characterization in Valve Homografts and Surgical Specimens. 83
Are FDA and CE sacrificing safety for a faster commercialization of xenogeneic tissue devices? Unavoidable need for legislation in decellularized tissue manufacturing 81
Mechanical Circulatory Support and Stem Cell-Based Heart Treatment in Europe—2018 Clinical Update 79
Biocompatibility Issues of Next Generation Decellularized Bioprosthetic Devices 76
Hybrid membranes for the production of blood contacting surfaces: physicochemical, structural and biomechanical characterization 69
Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: Implications for aortic valve calcification 66
NEW ALPHA-GAL REMOVAL ASSAY: PRESENCE AND DISTRIBUTION OF THE EPITOPE BEFORE AND AFTER CELL REMOVAL FROM XENOGENEIC HEART VALVES 63
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile 62
Covalent functionalization of decellularized tissues accelerates endothelialization 61
Spontaneous cell repopulation of valved conduits after decellularization and allogeneic transplantation 57
Tissue-Guided Regenerated Valved Conduits: Long-Term Results of Porcine Decellularized alpha-Gal Negative Roots 56
Novel heart valve replacement solutions based on self-assembling peptide-functionalized acellular pericardium 54
Time-course evaluation of tissue engineered valved conduits:long term results of porcine decellularized alpha-Gal- valves. 54
FLOGISTIC AND BIOCOMPATIBILITY EFFECTS DETERMINATION OF DECELLULARIZED AND COMMERCIAL AVAILABLE AORTIC LEAFLETS AFTER IMPLANTATION IN A PERITONEAL EXPERIMENTAL RAT MODEL 50
Present and future perspectives on total artificial hearts 50
From the anatomical study to the application of different bioengineering techniques for the creation of new vital heart valve substitutes 50
Modeling Cardiac Congenital Diseases: From Mathematic Tools to Human Induced Pluripotent Stem Cells 48
The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration 46
Alpha-Gal Removal Tool for the Creation of Xenogenic Biocompatible Heart Valve 45
Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy 45
In Vivo Spontaneous Tissue Regeneration Of Allogeneic Decellularized Aortic Valves. 44
Bioengineering the Cardiac Conduction System: Advances in Cellular, Gene, and Tissue Engineering for Heart Rhythm Regeneration 42
Ischemia sperimentale coronarica nel suino: variazioni anestesiologiche e indotte. 39
Cutting-Edge Regenerative Medicine Technologies for the Treatment of Heart Valve Calcification (Chapter 9) 37
Novel heart valve replacement solutions based on self-assembling peptide-functionalized acellular pericardium. 37
Evaluation of Decellularized Aortic Valve Leaflets Biocompatibility in a rat model 35
Popolazioni cellulari staminali nelle valvole cardiache umane: identificazione, isolamento e caratterizzazione in homograft valvolari e campioni chirurgici 35
Endotoxin and phosphate may contribute to valve calcification by inducing an osteogenic profile in a specific subset of interstitial aortic valve cells 34
New Generation Devices for Transcatheter Aortic Valve Implantation 34
Cellular, molecular, genomic changes occurring in the heart under mechanical circulatory support. 31
Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: Lessons from preclinical modeling 29
Biocompatibility Evaluation Criteria for Novel Xenograft Materials: Distribution and Quantification of Remnant Nucleic Acid and Alpha-Gal Epitope 28
Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies 28
Association of autoantibodies targeting endothelin type-A receptors with no-reflow in ST-elevation myocardial infarction 22
Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction 21
Association of Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Agonistic Autoantibodies With Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction 17
Spontaneous coronary artery dissection in women with acute myocardial infarction: is there a new role for autoimmunity? 14
Editorial: Insight in heart valve disease: 2021 12
Hybrid membranes for blood-contacting surfaces: preliminary characterization 12
Advances in the design, generation, and application of tissue-engineered myocardial equivalents 8
Editorial: Tissue and organ decellularization strategies in regenerative medicine; recent advances, current translational challenges, and future directions 4
Editorial: Vascular and valvular tissue engineering: Treating and modeling vasculopathies and valvulopathies 3
Totale 5.856
Categoria #
all - tutte 21.955
article - articoli 19.610
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 506
Totale 42.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.137 0 0 0 135 195 97 116 171 187 119 60 57
2020/2021900 48 82 47 91 42 42 16 71 151 161 92 57
2021/20221.024 28 91 96 181 42 63 46 134 54 9 69 211
2022/2023852 151 107 31 111 117 112 4 64 91 3 50 11
2023/2024416 19 66 47 41 23 29 28 25 20 25 40 53
2024/2025263 10 115 77 61 0 0 0 0 0 0 0 0
Totale 5.856